Literature DB >> 26634549

Association between TNF-α rs1799724 and rs1800629 polymorphisms and the risk of Crohn's disease.

Y Q Mao1, S Q Dong2, M Gao1.   

Abstract

We investigated the associations between 2 major tumor necrosis factor-α (TNF-α) polymorphisms, rs1799724 C>T and rs1800629 G>A, and the susceptibility to Crohn's disease (CD) using a meta-analysis framework. The PubMed, EBSCO, Ovid, Wiley, Web of Science, WANFANG, and VIP databases (last updated search in October 2014) were comprehensively searched for relevant published studies. The studies retrieved from database searches were filtered based on inclusion and exclusion criteria, and the resultant data extracted from the selected studies were analyzed using the Comprehensive Meta-analysis 2.0 software. Eleven case-control studies, containing 2000 CD patients and 3499 healthy controls, were identified as relevant to this meta-analysis. Data extracted from these 11 studies were analyzed to understand the role of the 2 TNF-α polymorphisms in CD. We found that the TNF-α rs1799724 C>T polymorphism increased the susceptibility to CD (allele model: OR = 1.293, 95%CI = 1.090-1.534, P = 0.003; dominant model: OR = 1.258, 95%CI = 1.031-1.534, P = 0.024). In contrast, we found no significant association between the TNF-α rs1800629 G>A polymorphism and CD susceptibility (allele model: OR = 1.005, 95%CI = 0.864-1.170, P = 0.945; dominant model: OR = 0.962, 95%CI = 0.809-1.145, P = 0.667). This meta-analysis showed that the TNF-α rs1799724 C>T polymorphism is associated with CD susceptibility, while the TNF-α rs1800629 G>A polymorphism appeared to have no correlation with the susceptibility to CD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26634549     DOI: 10.4238/2015.December.1.33

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  3 in total

1.  Genetic Association between TNFA Polymorphisms (rs1799964 and rs361525) and Susceptibility to Cancer in Systemic Sclerosis.

Authors:  Joanna Kosałka-Węgiel; Sabina Lichołai; Sylwia Dziedzina; Mamert Milewski; Piotr Kuszmiersz; Anna Rams; Jolanta Gąsior; Aleksandra Matyja-Bednarczyk; Helena Kwiatkowska; Mariusz Korkosz; Andżelika Siwiec; Paweł Koźlik; Agnieszka Padjas; Wojciech Sydor; Jerzy Dropiński; Marek Sanak; Jacek Musiał; Stanisława Bazan-Socha
Journal:  Life (Basel)       Date:  2022-05-07

2.  Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset.

Authors:  Sophie Steiner; Sonya C Becker; Jelka Hartwig; Franziska Sotzny; Sebastian Lorenz; Sandra Bauer; Madlen Löbel; Anna B Stittrich; Patricia Grabowski; Carmen Scheibenbogen
Journal:  Front Immunol       Date:  2020-04-09       Impact factor: 7.561

3.  Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.

Authors:  Valentina K Todorova; Issam Makhoul; Ishwori Dhakal; Jeanne Wei; Annjanette Stone; Weleetka Carter; Aaron Owen; V Suzanne Klimberg
Journal:  Oncol Res       Date:  2017-03-02       Impact factor: 5.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.